Delivery Order 36F79720D0237-36C26125N0262
Award Date
12/9/24
Potential Completion Date
1/9/25
Potential Value
$32K
Federal Agency
Veterans Integrated Service Network 21
Ultimate Awardee
Bayer AG
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Whippany, Hanover, NJ 07981, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $77,394.54 firm fixed-price delivery order contract awarded to Bayer Healthcare Pharmaceuticals Inc., a subsidiary of the global pharmaceutical company Bayer AG, by the Department of Veterans Affairs (VA) Integrated Service Network 22. The contract is for the delivery of the radiopharmaceutical Xofigo (radium Ra 223 dichloride) used in the treatment of prostate cancer. This award is part of Bayer's $840 million multiple award Federal Supply Schedule contract with the VA for...
This is a firm-fixed price delivery order contract awarded by the Veterans Integrated Service Network 7 (VISN 7), a component of the U.S. Department of Veterans Affairs (VA), to Bayer Healthcare Pharmaceuticals Inc. The contract is for the supply of the radiopharmaceutical drug Xofigo (radium Ra 223 dichloride) used in the treatment of prostate cancer. The contract has a ceiling value of $1,054,154.72 and a period of performance through June 2024. Bayer Healthcare Pharmaceuticals Inc. is a...
This is a federal contract award made by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit organization. The contract, valued at $458,110.23, is a delivery order under Bayer's $840 million multiple award Federal Supply Schedule contract with the VA for Pharmaceuticals and Drugs (FSS-61-IB). The contract is for the supply of Xofigo (radium Ra 223 dichloride), a radiopharmaceutical product used in the treatment of prostate cancer. This...
This is a $773,720.00 firm-fixed price delivery order contract awarded to Bayer Healthcare Pharmaceuticals Inc. by the Veterans Integrated Service Network 17 of the U.S. Department of Veterans Affairs (VA). The contract is for the supply of the radiopharmaceutical product Xofigo (radium Ra 223 dichloride) for the treatment of prostate cancer. This delivery order is placed against Bayer's $840 million multiple award schedule contract with the VA for pharmaceuticals and drugs. The contract has...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a subsidiary of the global pharmaceutical company Bayer AG. The contract, worth $89,775.53, is for the supply of the radiopharmaceutical medication Xofigo (radium Ra 223 dichloride) for the treatment of prostate cancer. The contract was awarded under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which has a potential...
This is a federal contract award by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit organization. The contract is for the delivery of Xofigo (radium Ra 223 dichloride) injections, a specialized pharmaceutical product used for the treatment of prostate cancer. The contract is a Delivery Order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a firm fixed price and a ceiling value of $111,938.48. The...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned for-profit pharmaceutical company. The order is for the supply of Xofigo (radium Ra 223 dichloride) injections, a prostate cancer treatment, to VA facilities. The award has a potential value of $292,836.43 and covers the period from November 1, 2019 to October 31, 2020. The contract was made under the VA's...
This federal contract award is for the delivery of the radiopharmaceutical product Xofigo (radium Ra 223 dichloride) to the Department of Veterans Affairs (VA) and other federal agencies. The contract, valued at $510,000.00, was awarded to the prime contractor Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The contract is a Delivery Order placed under Bayer's existing $840 million multiple award Federal Supply Schedule contract with the VA for...
This federal contract award to Bayer Healthcare Pharmaceuticals Inc. is for the delivery of Xofigo (radium Ra 223 dichloride), a pharmaceutical product used for the treatment of prostate cancer. The contract has a ceiling value of $100,001.04 and was awarded by the Department of Veterans Affairs (VA) under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract is a delivery order with a firm fixed price. It does not have a set-aside designation, indicating Bayer...
The U.S. Department of Veterans Affairs (VA) awarded a $63,171.18 firm-fixed price delivery order to Bayer Healthcare Pharmaceuticals Inc. to provide Xofigo (radium Ra 223 dichloride) for nuclear medicine. The order is part of Bayer's $840 million multiple award schedule contract with the VA for pharmaceutical and drug products, which supports veteran healthcare, military treatment facilities, and readiness programs. This delivery order has an ultimate completion date of August 13, 2025. The...